Fig. 5 demonstrates the relative (percentage) absorbed dose
reduction to the stomach, colon, remainder tissues, ovaries and
testes across each kVp. Fig. 5 clearly indicates that the most significant dose reduction is to the stomach, followed by the colon
and remainder tissues.